Yalniz-Akkaya Zuleyha, Burcu Ayse, Uney Guner O, Abay Iskan, Eksioglu Umit, Acar Mehmet Akif, Ornek Firdevs
Ophthalmology Department, Ankara Training and Research Hospital, Ankara, Turkey.
Middle East Afr J Ophthalmol. 2014 Jan-Mar;21(1):44-9. doi: 10.4103/0974-9233.124093.
The purpose of this study is to evaluate and to compare the results of primary and secondary scleral-fixated posterior chamber intraocular lens (PCIOL) implantations in adult patients.
A retrospective analysis of scleral-fixated PCIOLs-implanted during (primary group) or after (secondary group) cataract surgery was performed. The median follow-up time of 96 patients was 6 months (minimum: 6; maximum: 35 months). Outcome measures were indications, corrected distance visual acuity (CDVA), change in visual acuity and complications.
A total of 37 patients (38.5%) had primary implantations and 59 (61.5%) had secondary implantations. Penetrating keratoplasty was combined with secondary implantation in 13 cases. The median post-operative CDVA was 0.5 in decimal notation in both groups (P = 0.576). The CDVA improved by at least one Snellen line or remained unchanged in 35 eyes (94.6%) in the primary group and in 52 eyes (88.1%) in the secondary group (P = 0.263). Eyes with CDVA of 0.5 or higher were 62.2% (n = 23) in the primary group and 67.8% (n = 40) in the secondary group post-operatively (P = 0.066). The difference in early and late complications were not statistically significant between groups (P = 0.637, P = 0.154, respectively). Regarding late complications, 30 eyes (81%) in the primary group and 40 eyes (67.9%) in the secondary group had no complications (P = 0.154).
Both primary and secondary scleral-fixated PCIOL implantations can provide favorable visual outcomes with lower complication rates. An important consideration is the appropriate timing for scleral fixation, taking into account the patient's characteristics and the course of the operation.
本研究旨在评估和比较成年患者初次和二次巩膜固定后房型人工晶状体(PCIOL)植入术的结果。
对白内障手术期间(初次植入组)或之后(二次植入组)植入巩膜固定PCIOL的患者进行回顾性分析。96例患者的中位随访时间为6个月(最短:6个月;最长:35个月)。观察指标包括适应证、矫正远视力(CDVA)、视力变化及并发症。
共有37例患者(38.5%)接受了初次植入,59例(61.5%)接受了二次植入。13例二次植入患者联合了穿透性角膜移植术。两组术后CDVA中位数均为小数记录法的0.5(P = 0.576)。初次植入组35只眼(94.6%)的CDVA提高至少一行或保持不变,二次植入组52只眼(88.1%)如此(P = 0.263)。术后CDVA为0.5或更高的眼,初次植入组为62.2%(n = 23),二次植入组为67.8%(n = 40)(P = 0.066)。两组早期和晚期并发症的差异无统计学意义(分别为P = 0.637,P = 0.154)。关于晚期并发症,初次植入组30只眼(81%)和二次植入组40只眼(67.9%)无并发症(P = 0.154)。
初次和二次巩膜固定PCIOL植入术均可提供良好的视力结果且并发症发生率较低。重要的是要根据患者的特点和手术过程考虑巩膜固定的合适时机。